Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Invested Capital (2020 - 2025)

Celularity (CELU) has disclosed Invested Capital for 6 consecutive years, with -$15.8 million as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital fell 191.49% to -$15.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$15.8 million, a 191.49% decrease, with the full-year FY2024 number at $11.3 million, down 81.22% from a year prior.
  • Invested Capital was -$15.8 million for Q3 2025 at Celularity, up from -$21.2 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $236.5 million in Q4 2022 to a low of -$648.2 million in Q2 2021.
  • A 5-year average of $3.3 million and a median of $44.3 million in 2023 define the central range for Invested Capital.
  • Peak YoY movement for Invested Capital: surged 137.89% in 2022, then plummeted 191.49% in 2025.
  • Celularity's Invested Capital stood at $99.4 million in 2021, then surged by 137.89% to $236.5 million in 2022, then plummeted by 74.51% to $60.3 million in 2023, then tumbled by 81.22% to $11.3 million in 2024, then crashed by 239.64% to -$15.8 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Invested Capital are -$15.8 million (Q3 2025), -$21.2 million (Q2 2025), and -$3.0 million (Q1 2025).